Revision notes โ€บ Rheumatology & metabolic bone

Osteoporosis and fragility fractures

Osteoporosis is a skeletal disorder of low bone mass and poor microarchitecture that makes bones fracture with little trauma. Every fragility fracture is a chance to prevent the next one, and orthopaedic surgeons are responsible for making sure that secondary prevention happens.

Key points

  • A fragility fracture follows a fall from standing height or less.
  • WHO DXA: osteoporosis is a T-score of -2.5 or below.
  • A first fragility fracture doubles the risk of another, especially in the first two years.
  • Oral bisphosphonates are first line; IV zoledronate after hip fracture is common.
  • Never stop denosumab without follow-on bisphosphonate (rebound vertebral fractures).
  • Atypical femoral fractures: lateral cortical beaking, prodromal pain, check the other side.
  • In osteoporotic bone use load-sharing, locking or arthroplasty options and allow full weight bearing.
  • Every fragility fracture should trigger Fracture Liaison Service assessment.

The basics

A fragility fracture is one that results from a fall from standing height or less, or from no identifiable trauma. Typical sites are the hip, vertebrae, distal radius, proximal humerus and pelvis.

Osteoporosis is common, especially in postmenopausal women and older men. Vertebral fractures are the most common osteoporotic fracture, but many are never diagnosed.

A first fragility fracture roughly doubles the risk of another, and the risk is highest in the first year or two (imminent fracture risk). Hip fractures carry high mortality and loss of independence.

In the UK, Fracture Liaison Services identify patients with fragility fractures and arrange assessment and treatment, and the Royal Osteoporosis Society sets clinical standards for them.

Pathophysiology

Bone is constantly remodelled by osteoclasts (resorption) and osteoblasts (formation), coordinated by osteocytes. The RANK-RANKL-osteoprotegerin system is central: RANKL activates osteoclasts, and osteoprotegerin is its decoy receptor.

Peak bone mass is reached in early adulthood, then bone is gradually lost, accelerating after menopause as oestrogen falls.

Type of loss:

  • Postmenopausal (high turnover), mainly trabecular bone, linked to vertebral and distal radius fractures
  • Age-related, affecting cortical and trabecular bone, linked to hip fractures
  • Secondary osteoporosis from other conditions

Secondary causes to look for include glucocorticoid use, hypogonadism, hyperthyroidism, hyperparathyroidism, malabsorption (such as coeliac disease), chronic kidney or liver disease, rheumatoid arthritis, myeloma, alcohol excess, smoking, low body weight and drugs such as aromatase inhibitors and androgen deprivation therapy.

Never miss

  • Thigh pain in a patient on long-term bisphosphonates (incomplete atypical femoral fracture).
  • A low-trauma fracture with anaemia, hypercalcaemia or renal impairment (consider myeloma).

Common pitfalls

  • Treating the fracture and forgetting secondary prevention.
  • Missing secondary causes such as myeloma, hyperparathyroidism or coeliac disease.
  • Stopping denosumab abruptly.
  • Fixing an atypical femoral fracture with a short device and not imaging the other femur.

Read the full note (5 more sections) and test yourself

Free for everyone, no card: exam-style questions on osteoporosis and fragility fractures with every option explained, real X-rays, and a Consultant on Call to explain anything you get wrong.

Create a free account โ†’ Log in

Further reading: ["NICE CG146: Osteoporosis: assessing the risk of fragility fracture (2012, updated).","National Osteoporosis Guideline Group (NOGG): UK clinical guideline for the prevention and treatment of osteoporosis (2022 update).","NICE CG124: Hip fracture: management.","Royal Osteoporosis Society: Clinical standards for Fracture Liaison Services."]

โ† All revision notes ยท Question of the day ยท X-ray of the day